Johnson & Johnson DRC (JNJ)

Currency in CAD
34.55
-0.55(-1.57%)
Closed·
Advertisement
JNJ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
34.5534.63
52 wk Range
22.7235.20
Key Statistics
Prev. Close
34.55
Open
34.63
Day's Range
34.55-34.63
52 wk Range
22.72-35.2
Volume
209
Average Volume (3m)
3.64K
1-Year Change
47.3976%
Book Value / Share
50.06
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
JNJ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Johnson & Johnson DRC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
15/07/2026
EPS / Forecast
2.27 / --
Revenue / Forecast
25.31B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 8.63%
Dividend Yield
1.98%
Industry Median 2.06%
Annualised payout
0.68
Paid quarterly
5-Years Growth
+5.08%
Growth Streak

Compare JNJ to Peers and Sector

Metrics to compare
JNJ
Peers
Sector
Relationship
P/E Ratio
0.0x24.5x−0.4x
PEG Ratio
0.000.080.00
Price/Book
0.0x5.7x2.6x
Price / LTM Sales
0.0x2.4x3.1x
Upside (Analyst Target)
0.0%0.0%48.6%
Fair Value Upside
Unlock9.4%5.8%Unlock

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Employees
138200
Market
Canada

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
919.81M38.17%31.93B
Other Institutional Investors
920.97M38.22%31.97B
Public Companies & Retail Investors
569.12M23.62%19.75B
Total
2.41B100.00%83.65B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.8.80%212,098,2647,361,931
Vanguard Capital Management, LLC7.09%170,743,4445,926,505

FAQ

What Is the Johnson Johnson DRC (CBOE Canada: JNJ) Share Price Today?

The Johnson Johnson DRC stock price today is 34.55 CAD.

What Stock Exchange Does Johnson Johnson DRC (JNJ) Trade On?

Johnson Johnson DRC is listed and trades on the CBOE Canada Exchange.

What Is the Ticker (Stock Symbol) for Johnson Johnson DRC?

The stock symbol (also called a 'ticker') for Johnson Johnson DRC is "JNJ."

Does Johnson Johnson DRC Pay Dividends? What’s The Current JNJ Dividend Yield?

Yes, JNJ Pays Dividends to its Shareholders. The current Johnson Johnson DRC dividend yield is 1.98%.

What Is the Current Johnson Johnson DRC Market Capitalisation?

As of today, Johnson Johnson DRC (CBOE Canada: JNJ) market cap is 898.27B CAD.

What Is Johnson Johnson DRC's (JNJ) Earnings Per Share (TTM)?

The Johnson Johnson DRC EPS is currently 8.63 (Trailing Twelve Months).

Is JNJ a Buy or Sell From a Technical Analyst Perspective?

Based on today's Johnson Johnson DRC moving averages and other technical indicators, the daily buy/sell signal for JNJ stock is Strong Buy.

How Many Times Has Johnson Johnson DRC Stock Split?

Johnson Johnson DRC has split 0 times. (See the JNJ stock split history page for full effective split date and price information.)

How Many Employees Does Johnson Johnson DRC Have?

Johnson Johnson DRC has 138200 employees, based on their latest Companies House report.

What is the current trading status of Johnson Johnson DRC (CBOE Canada: JNJ)?

As of 24/08/2026, Johnson Johnson DRC (JNJ) is trading at a share price of 34.55 CAD, with a previous close of 34.55 CAD. The stock has fluctuated within a day range of 34.55 CAD to 34.63 CAD, while its 52-week range spans from 22.72 CAD to 35.20 CAD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.